4-156970888-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016205.3(PDGFC):c.16C>T(p.Leu6Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016205.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDGFC | NM_016205.3 | c.16C>T | p.Leu6Phe | missense_variant | 1/6 | ENST00000502773.6 | |
PDGFC | NR_036641.2 | n.912C>T | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDGFC | ENST00000502773.6 | c.16C>T | p.Leu6Phe | missense_variant | 1/6 | 1 | NM_016205.3 | P1 | |
PDGFC | ENST00000274071.6 | c.16C>T | p.Leu6Phe | missense_variant, NMD_transcript_variant | 1/7 | 1 | |||
PDGFC | ENST00000422544.2 | c.16C>T | p.Leu6Phe | missense_variant | 1/6 | 5 | |||
PDGFC | ENST00000513664.1 | n.78C>T | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460550Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726550
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.16C>T (p.L6F) alteration is located in exon 1 (coding exon 1) of the PDGFC gene. This alteration results from a C to T substitution at nucleotide position 16, causing the leucine (L) at amino acid position 6 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.